Stocks / NYSE / Ambrx Biopharma Inc.

Ambrx Biopharma Inc.

Our Opinion

Ambrx Biopharma Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“We are advancing several targeted TLR7/8 ISAC constructs, with the first program having recently achieved preclinical proof of concept, including potent immune cell activation in a target-specific manner in various immune signaling assays and anti-tumor activity in animal models.” (Page 170) Read the full document

Company Description

Ambrx Biopharma Inc. is a clinical-stage biologics company, which is focused on discovering and developing a class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids (SAA) that do not exist in nature into proteins within living cells.

Company Website: